At Sanarus Technologies we think that women deserve a better outcome.


Our Story:
Sanarus is an innovative medical device company with a commercially available minimally invasive treatment for breast lesions, the Visica 2TM Treatment System. This year alone, 770,000 new breast tumors will be diagnosed with 20% being malignant4,5 and we believe that women deserve an option that is more effective than surgery.

The Visica 2 Treatment System has FDA clearance for cryoablation of cancerous tissue and non-cancerous tumors. Sanarus is currently sponsoring the FROST Clinical Study.





















1. http://beforeitsnews.com/health/2014/09/lumpectomy-as-effective-as-double-mastectomy-2548600.html
2.https://www.breastsurgeons.org/statements/PDF_Statements/Lumpectomy_Margins.pdf
3. http://www.ascopost.com/issues/march-1-2012/reexcision-rates-following-breast-conservation-surgery-vary-widely.aspx
4. www.nationalbreastcancer.org/breast-cancer-facts
5. www.cancer.org/acs/groups/cid/documents/webcontent/003176-pdf.pdf

A message from our Chairman...

"Being a woman, I understand that this may be a very difficult time for you and your family. That's why we are committed to give you the information and education you need to make an informed decision. We welcome you to contact us today with your questions and we will do our best to help you."

Sincerely,

BJ Hardman 

 


 

Cryotherapy Procedure featuring Dr. Charles Cox of USF